483
Patheon Italia S.p.A.Patheon Italia S.p.A. – FDA 483, May 26, 2023
Record Details
An FDA inspection of Patheon Italia S.p.A. in Monza, Italy, a sterile drug manufacturer, revealed significant deficiencies across multiple areas. Observations included inadequate environmental monitoring in aseptic processing, scientifically unjustified media fill designs for sterile products, and improperly qualified equipment. Additionally, the firm's warehouse lacked scientifically-driven temperature mapping studies for drug product storage.
View Company Profile
ID · 79cf157f-fd82-4b03-8b1c-6b688732e007
Other documents for Patheon Italia S.p.A.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.